DYKAN JEFF enters REGENTIS BIOMATERIALS LTD. with 400.94K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Indirect Derivatives
Filed: 3/18/2026ACC: 0001213900-26-030773
400.94K
Baseline shares
0.00
Direct ownership
0 positions
8.21K
Derivative underlying
2 instruments
2
Security positions
400.94K indirect
Non-Derivative Holdings2
Ordinary Shares, no par value per share
IndirectShares owned130.47K
Ordinary Shares, no par value per share
IndirectShares owned270.47K
Total
400.94K indirect400.94K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Ordinary Shares, no par value per share | 130.47K | Indirect |
| Ordinary Shares, no par value per share | 270.47K | Indirect |
| Total | 400.94K | 400.94K indirect |
Derivative Holdings2
Warrants to purchase ordinary shares
IndirectUnderlying security
Common Stock
Underlying shares
6.12K
Shares owned
N/A
Exercise price
5.00
Expiration
—
Exercise window
—
Warrants to purchase ordinary shares
IndirectUnderlying security
Common Stock
Underlying shares
2.08K
Shares owned
N/A
Exercise price
5.00
Expiration
—
Exercise window
—
Total
Underlying
8.21K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Warrants to purchase ordinary shares Indirect | Common Stock | 5.00 | — | — | 6.12K | N/A |
| Warrants to purchase ordinary shares Indirect | Common Stock | 5.00 | — | — | 2.08K | N/A |
| Total | 8.21K | 0.00 | ||||